Relmada Therapeutics, Inc
Relmada Therapeutics, Inc

Relmada Therapeutics, Inc Information

Contact top employees from Relmada Therapeutics, Inc

Summary

Relmada Therapeutics, Inc is a public company that has been in the industry for 22 years. The company currently specializes in the Pharmaceuticals, Biotechnology areas. The position of the CEO is occupied by Sergio Traversa. Its headquarters is located at Coral Gables, Florida, USA. The number of employees ranges from 1 to 25. The annual revenue of Relmada Therapeutics, Inc varies between 5.0M and 25M. Total funding of the company - $164.9M. To connect with Relmada Therapeutics, Inc employee register on SignalHire.

Organization Website

relmada.com

Social Links

linkedIntwitter

Phone Number

1-646-876-3459

Industries

Headquarters Location

2222 Ponce de Leon Blvd, Coral Gables, Florida, 33134 US

Employees Size

10-50 employees

Specialties

Pharmaceutical Development

SIC Code

2834

DMA Code

Miami Metropolitan Area

Founded

2004

Estimated Annual Revenue

$5.0M - 25M

Operating Status

Independent Company

Competitors

Founded
Type
Employees
Revenue
Funding
2005Public
Company
1 - 25 < 1M $38.8M
1995Public
Company
100 - 250 30.4M $234.5M
2006Privately
Held
25 - 100 5M $74.8M
2000Privately
Held
25 - 100 6M $222.9M

Employees Turnover 4 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at Relmada Therapeutics, Inc shows a diverse range of experience levels:
7% have been with the company for less than 1 year14% for 1–2 years14% for 3–4 years14% for 5–7 years14% for 8–10 years36% have over 11 years of service at Relmada Therapeutics, Inc
Ex-employees positions
In Company
In New Company
Contact top employees from Relmada Therapeutics, Inc
Alyssa Erhartic
Senior R&D Coordinator
View
Alan Burns
Sr. Vice President, Quality
View
Andrea Varalli
Executive Vice President of Brand Experience
View
Enrique Comesaña Diaz
SVP, Clinical Development- Head of Medical & Safety
View
Paul Greene
Senior Vice President, Clinical Operations
View
Ottavio Vitolo
SVP, Head of R&D and CMO
View
Cornelia Kroeger
Senior Vice President Operations
View
Preeti Chirmule
Vice President
View
Travis Buel
Vice President, Manufacturing and Tech Ops
View
Scott White
Director of Clinical Operations
View
Alyson Jacoff
Accounting Manager
View
Steve
Clinical Research Scientist
View
Samita Kumar
Clinical Project Manager-Vendor
View
Dhiviya Samuel
Clinical supply manager
View
Raj Pruthi
Chief Medical Officer-Urology
View
Maged Shenouda
Chief Financial Officer
View
Cindy Kurak
Director, Medical Affairs/Clinical Trials and Program Development
View
Marge Mitchell
Senior Director, Medical and Clinical Operations
View
Tricia Bergland
Senior Clinical Research Scientist
View
Donna
Executive Adminstrator
View

FAQ

Relmada Therapeutics, Inc operates in the Pharma industries. More details can be found on the official website: relmada.com.
The headquarters of Relmada Therapeutics, Inc are located in Coral Gables, United States.
The current CEO of Relmada Therapeutics, Inc is Sergio Traversa
You can contact Relmada Therapeutics, Inc by phone at 1-646-876-3459.
Relmada Therapeutics, Inc currently employs 10-50 people.
You can contact Relmada Therapeutics, Inc by phone at 1-646-876-3459, by email at straversa@relmada.com, through social media (LinkedIn, Twitter), or via the contact form on relmada.com.
Relmada Therapeutics, Inc's revenue is approximately 6.3M.
Well-known competitors of Relmada Therapeutics, Inc include InVivo Therapeutics, Egalet Corporation, Curemark, LLC and Alexza / Ferrer.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP